AELIX THERAPEUTICS
Aelix Therapeutics develops therapeutic vaccines and immunotherapies to treat HIV infection. The company is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was created under the leadership of its founders, Dr. Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Mr. Jordi Naval; all of whom have several decades of experience in HIV and biotech development. The company’s know-how will further expand through unique immunogen designs. It will also benefit from ready access to large cohorts of HIV infected patients in several continents through its partnership with the HIVACAT consortium.
AELIX THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.aelixtherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(514) 367 1212
Email Addresses:
[email protected]
Total Funding:
13.41 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
CDTI
CDTI investment in Venture Round - Aelix Therapeutics
Ysios Capital
Ysios Capital investment in Venture Round - Aelix Therapeutics
Caixa Capital Risc
Caixa Capital Risc investment in Venture Round - Aelix Therapeutics
EIT Health
EIT Health investment in Grant - Aelix Therapeutics
Caixa Capital Risc
Caixa Capital Risc investment in Series A - Aelix Therapeutics
Ysios Capital
Ysios Capital investment in Series A - Aelix Therapeutics
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series A - Aelix Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-05-18 | AELIX Therapeutics appoints Dr Melanie Rolli as CEO |
Official Site Inspections
http://www.aelixtherapeutics.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.33 K
- Host name: hosting01.servidoresdns.net
- IP address: 217.76.128.34
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Aelix Therapeutics"
Aelix Therapeutics - Crunchbase Company Profile & Funding
Organization. Aelix Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
AELIX Therapeutics - LinkedIn
AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication …See details»
AELIX’s Assets Acquired by Gilead Sciences– Ysios Capital
Barcelona, Spain, November 25, 2024 – AELIX Therapeutics, a biopharmaceutical company based in Barcelona, Spain, that focuses on HIV vaccine development, today announced that …See details»
AELIX’s HTI HIV Vaccine Investigational Assets Acquired by Gilead …
Email: [email protected]. Author: Thomas Hecht Created Date: 11/22/2024 11:09:47 AM ...See details»
AELIX Therapeutics Company Profile | Management and
AELIX Therapeutics Profile and History. AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV …See details»
Aelix Therapeutics Company Profile - Office Locations ... - Craft
Aelix Therapeutics has 5 employees at their 1 location and $12.62 m in total funding,. See insights on Aelix Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Aelix Therapeutics SL - Company Profile and News
Company profile page for Aelix Therapeutics SL including stock price, company news, executives, board members, and contact informationSee details»
AELIX Therapeutics Information - RocketReach
Aelixtherapeutics.com; 4 516248XXXX; 35191602XXXX; 35196726XXXX; 35196322XXXX; Álvaro Aranguren Ibáñez CSM Junior and Project Manager at AELIX Therapeutics Barcelona, …See details»
Aelix Therapeutics - PitchBook
Aelix Therapeutics General Information Description. Operator of a therapeutic vaccine biotechnology company intended to cure HIV infection. The company's vaccine is based on an …See details»
AELIX Therapeutics Overview | SignalHire Company Profile
Phone Number: 34-93-403-13-39,(514) 367 1212: AELIX Therapeutics industries Biotech, Health Care ServicesSee details»
AELIX Therapeutics
About: AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in …See details»
Aelix Therapeutics | IT History Society
AELIX Therapeutics, a drug development company specialized in the discovery and development of immunotherapies for HIV infectionAelix Therapeutics develops therapeutic vaccines and …See details»
Aelix Therapeutics - VentureRadar
The nonprofit portion of the project is fiscally sponsored by the HIV/AIDS charity Until There's a Cure. The vaccine is being developed by Flow Pharma. The project is the second nonprofit …See details»
AELIX Therapeutics appoints Dr Melanie Rolli as CEO
May 18, 2021 www.aelixtherapeutics.com. Contacts. Amanda Bown, [email protected] Juliette Schmitt, [email protected]. Andrew Lloyd & Associates Tel: +44 1273 675 100 @ALA_Group . …See details»
AELIX Therapeutics Company Overview, Contact Details
Aelixtherapeutics launches HIV vaccine. Emerging Company Profile: Aelix Therapeutics has constructed a potential therapeutic HIV vaccine to refocus the immune system onto vulnerable …See details»
Aelix Therapeutics - VentureRadar
Website: http://aelixtherapeutics.com. Develops therapeutic HIV vaccines, based in Barcelona, focusing on cure/eradication strategies, originating from public-private ...See details»
AELIX Therapeutics | Insights
Aug 11, 2022 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Nextsource | Company Profile | Aelix Therapeutics
Explore the company profile of Aelix Therapeutics (aelixtherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
AELIX Therapeutics presents positive results from randomized …
Barcelona, Spain, March 10, 2021 – AELIX Therapeutics S.L. (‘AELIX’), a clinical-stage biotechnology company specialized in the discovery and development of immunotherapies for …See details»
Aelix Therapeutics - EU-Startups
AELIX Therapeutics is a clinical-stage biotechnology company focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies.See details»